Fusion protein vectors to increase protein production and evaluate the immunogenicity of genetic vaccines

Molecular Therapy

Volumn 2, Issue 3, 2000, Pages 288-297

  Wu, Lei ^a   Barry, Michael A ^a,b,c,d  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Rice University   (United States)

^d NONE   (United States)

Author keywords

Antibody production; DNA vaccines; Genetic immunization; Protein expression

Indexed keywords

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA;

ALPHA 1 ANTITRYPSIN; GLYCOPROTEIN GP 120; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; PHOTOPROTEIN; RECOMBINANT VACCINE;

ARTICLE; CELL LINE; COMPARATIVE STUDY; EVALUATION; GENE VECTOR; GENETICS; HUMAN; IMMUNOLOGY;

ALPHA 1-ANTITRYPSIN; CELL LINE; EVALUATION STUDIES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HIV ENVELOPE PROTEIN GP120; HUMANS; LUMINESCENT PROTEINS; RECOMBINANT FUSION PROTEINS; VACCINES, SYNTHETIC;

EID: 0034267310     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2000.0126     Document Type: Article

References (19)

1. Tang, D., DeVit, M., and Johnston, S. A. (1992). Genetic immunization is a simple method for eliciting an immune response. Nature 356: 152-154.
2. Ulmer, J. B., et al. (1993). Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259: 1745-1749.
3. Wang, B., et al. (1993). Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90: 4156-4160.
4. Barry, M. A., Barry, M. E., and Johnston, S. A. (1994). Production of monoclonal antibodies by genetic immunization. Biotechniques 16: 616-619.
5. Yeung, S. C, Kobayashi, K., Oka, K., and Chan, L. (1997). Production of rabbit polyclonal antibody against apobec-1 by genetic immunization. J. Lipid Res. 38: 2627-2632.
6. Fuller, D. H., Corb, M. M., Barnett, S., Steimer, K., and Haynes, J. R. (1997). Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques. Vaccine 15: 924-926.
7. Barnett, S. W., et al. (1997). Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 subunit. Vaccine 15: 869-873.
8. Barry, M. A., and Johnston, S. A. (1996). Biological features of genetic immunization. Vaccine 15: 788-791.
9. Haas, J., Park, E. C., and Seed, B. (1996). Codon usage limitation in the expression of HIV-1 envelope glycoprotein. Curr. Biol. 6: 315-324.
10. Andre, S., Seed, B., Eberle, J., Schraut, W., Bultmann, A., and Haas, J. (1998). Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J. Virol. 72: 1497-1503.
11. Barry, M. A., Lai, W. C., and Johnston, S. A. (1995). Protection against mycoplasma infection using expression library immunization: A general approach to vaccine development. Nature 377: 632-635.
12. Reitter, J. N., Means, R. E., and Desrosiers, R. C. (1998). A role for carbohydrates in immune evasion in AIDS. Nat. Med. 4: 679-684.
13. Sykes, K. F., and Johnston, S. A. (1999). Genetic live vaccines mimic the antigenicity but not pathogenicity of live viruses. DNA Cell Biol. 18: 521-531.
14. Inchauspe, G., et al. (1997). Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: Comparative studies of antibody and T-helper responses following genetic immunization. DNA Cell Biol. 16: 185-195.
15. Parrott, M. B., and Barry, M. A. (2000). Metabolic biotinylation of recombinant proteins in mammalian cells and in mice. Mol. Ther. 1: 96-104.
16. Schubert, U., Anton, L. C., Gibbs, J., Norbury, C. C., Yewdell, J. W., and Bennink, J. R. (2000). Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404: 770-774.
17. VanCott, T. C., et al. (1997). Antibodies with specificity to native gp120 and neutralization activity against primary human immunodeficiency virus type 1 isolates elicited by immunization with oligomeric gp160. J. Virol. 71: 4319-4330.
18. Xiong, S., Gerloni, M., and Zanetti, M. (1997). Engineering vaccines with heterologous B and T cell epitopes using immunoglobulin genes. Nat. Biotechnol. 15: 882-886.
19. Boyle, J. S., Brady, J. L., and Lew, A. M. (1998). Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature 392: 408-410.